The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.

about

Comparative Pharmacokinetics and Preliminary Pharmacodynamics Evaluation of Piscidin 1 Against PRV and PEDV in Rats.

P2860

Q55471456-2B0F3792-8CB7-48A6-AB8D-0FCA9E4B9CD3

P2860

The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.

Item

http://www.wikidata.org/entity/Q49210057

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The pharmacokinetic-pharmacody ...... against Haemophilus parasuis.

@en

The pharmacokinetic-pharmacody ...... against Haemophilus parasuis.

@nl

type

Item

label

The pharmacokinetic-pharmacody ...... against Haemophilus parasuis.

@en

The pharmacokinetic-pharmacody ...... against Haemophilus parasuis.

@nl

prefLabel

The pharmacokinetic-pharmacody ...... against Haemophilus parasuis.

@en

The pharmacokinetic-pharmacody ...... against Haemophilus parasuis.

@nl

P1476

The pharmacokinetic-pharmacody ...... against Haemophilus parasuis.

@en

P2093

Bing Yang

http://www.w3.org/2001/XMLSchema#string

Jiyue Cao

http://www.w3.org/2001/XMLSchema#string

Qianying Liu

http://www.w3.org/2001/XMLSchema#string

Qigai He

http://www.w3.org/2001/XMLSchema#string

Saeed Ahmed

http://www.w3.org/2001/XMLSchema#string

Zhixin Lei

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance.

Macrolide antibiotics, drug interactions and microsomal enzymes: implications for veterinary medicine.

Clinical Efficacy and Residue Depletion of 10% Enrofloxacin Enteric-Coated Granules in Pigs

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Pharmacokinetic and pharmacodynamic modeling of cyadox against Clostridium perfringens in swine.

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.

Effects of AIDS and gender on steady-state plasma and intrapulmonary ethionamide concentrations.

A review of membrane sampling from biological tissues with applications in pharmacokinetics, metabolism and pharmacodynamics.

Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis

In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis

P304

1673-1690

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23018

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29416722

http://www.w3.org/2001/XMLSchema#string

P932

5788590

http://www.w3.org/2001/XMLSchema#string

The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.

about

P2860

P2860

The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932